Skip to content
10-K

Annual Report

Sio Gene Therapies Inc.

0001636050-22-000035

← back to feed
Filed
Jun 14, 2022 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2022 · Jun 10, 2022 73.74M sh
Shares Diluted FY 2022 · Mar 31, 2022 73.21M sh
Shares Diluted FY 2022 · Mar 31, 2021 52.18M sh
Operating Cash Flow FY 2022 · Mar 31, 2022 −$60.35M
Operating Cash Flow FY 2022 · Mar 31, 2021 −$46.59M
Cash And Equivalents FY 2022 · Mar 31, 2022 $63.73M
Cash And Equivalents FY 2022 · Mar 31, 2021 $118.99M
Cash And Equivalents FY 2022 · Mar 31, 2020 $80.75M
Stockholders Equity FY 2022 · Mar 31, 2022 $60.35M
Stockholders Equity FY 2022 · Mar 31, 2021 $123.37M
Stockholders Equity FY 2022 · Mar 31, 2020 $61.56M
Current Liabilities FY 2022 · Mar 31, 2022 $13M
Current Liabilities FY 2022 · Mar 31, 2021 $10.85M
Total Liabilities FY 2022 · Mar 31, 2022 $14.73M
Total Liabilities FY 2022 · Mar 31, 2021 $11.78M
Current Assets FY 2022 · Mar 31, 2022 $71.74M
Current Assets FY 2022 · Mar 31, 2021 $132.33M
Total Assets FY 2022 · Mar 31, 2022 $75.08M
Total Assets FY 2022 · Mar 31, 2021 $135.15M
Eps Diluted FY 2022 · Mar 31, 2022 −$0.18
Eps Diluted FY 2022 · Mar 31, 2022 −$0.98
Eps Diluted FY 2022 · Dec 31, 2021 −$0.35
Eps Diluted FY 2022 · Sep 30, 2021 −$0.29
Eps Diluted FY 2022 · Jun 30, 2021 −$0.16
Eps Diluted FY 2022 · Mar 31, 2021 −$0.05
Eps Diluted FY 2022 · Mar 31, 2021 −$0.62
Eps Diluted FY 2022 · Dec 31, 2020 −$0.20
Eps Diluted FY 2022 · Sep 30, 2020 −$0.21
Eps Diluted FY 2022 · Jun 30, 2020 −$0.20
Eps Basic FY 2022 · Mar 31, 2022 −$0.18
Eps Basic FY 2022 · Mar 31, 2022 −$0.98
Eps Basic FY 2022 · Dec 31, 2021 −$0.35
Eps Basic FY 2022 · Sep 30, 2021 −$0.29
Eps Basic FY 2022 · Jun 30, 2021 −$0.16
Eps Basic FY 2022 · Mar 31, 2021 −$0.05
Eps Basic FY 2022 · Mar 31, 2021 −$0.62
Eps Basic FY 2022 · Dec 31, 2020 −$0.20
Eps Basic FY 2022 · Sep 30, 2020 −$0.21
Eps Basic FY 2022 · Jun 30, 2020 −$0.20
Sga Expense FY 2022 · Mar 31, 2022 $470K
Sga Expense FY 2022 · Mar 31, 2022 $18.16M
Sga Expense FY 2022 · Dec 31, 2021 $4.09M
Sga Expense FY 2022 · Sep 30, 2021 $9.75M
Sga Expense FY 2022 · Jun 30, 2021 $3.86M
Sga Expense FY 2022 · Mar 31, 2021 $3.97M
Sga Expense FY 2022 · Mar 31, 2021 $17.29M
Sga Expense FY 2022 · Dec 31, 2020 $4.2M
Sga Expense FY 2022 · Sep 30, 2020 $4.49M
Sga Expense FY 2022 · Jun 30, 2020 $4.64M
Rd Expense FY 2022 · Mar 31, 2022 $12.61M
Rd Expense FY 2022 · Mar 31, 2022 $53.4M
Rd Expense FY 2022 · Dec 31, 2021 $21.29M
Rd Expense FY 2022 · Sep 30, 2021 $11.45M
Rd Expense FY 2022 · Jun 30, 2021 $8.06M
Rd Expense FY 2022 · Mar 31, 2021 $8.24M
Rd Expense FY 2022 · Mar 31, 2021 $24.9M
Rd Expense FY 2022 · Dec 31, 2020 $6.41M
Rd Expense FY 2022 · Sep 30, 2020 $5.06M
Rd Expense FY 2022 · Jun 30, 2020 $5.19M
Net Income FY 2022 · Mar 31, 2022 −$13.32M
Net Income FY 2022 · Mar 31, 2022 −$71.89M
Net Income FY 2022 · Dec 31, 2021 −$25.46M
Net Income FY 2022 · Sep 30, 2021 −$21.24M
Net Income FY 2022 · Jun 30, 2021 −$11.87M
Net Income FY 2022 · Mar 31, 2021 −$3.33M
Net Income FY 2022 · Mar 31, 2021 −$32.43M
Net Income FY 2022 · Dec 31, 2020 −$10.52M
Net Income FY 2022 · Sep 30, 2020 −$9.98M
Net Income FY 2022 · Jun 30, 2020 −$8.59M
Operating Income FY 2022 · Mar 31, 2022 −$71.63M
Operating Income FY 2022 · Mar 31, 2021 −$32.64M